Core Laboratories N.V. Company Profile (NYSE:CLB)

About Core Laboratories N.V. (NYSE:CLB)

Core Laboratories N.V. logoCore Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Industry, Sector and Symbol:
  • Sector: Oils/Energy
  • Industry: Oil Related Services and Equipment
  • Sub-Industry: N/A
  • Symbol: NYSE:CLB
  • CUSIP: N/A
  • Web:
  • Market Cap: $4.02 billion
  • Outstanding Shares: 44,138,000
Average Prices:
  • 50 Day Moving Avg: $94.86
  • 200 Day Moving Avg: $101.72
  • 52 Week Range: $86.55 - $125.83
  • Trailing P/E Ratio: 55.88
  • Foreward P/E Ratio: 33.49
  • P/E Growth: 1.28
Sales & Book Value:
  • Annual Revenue: $614.73 million
  • Price / Sales: 6.54
  • Book Value: $3.34 per share
  • Price / Book: 27.27
  • Annual Dividend: $2.20
  • Dividend Yield: 2.3%
  • EBITDA: $123.03 million
  • Net Margins: 11.80%
  • Return on Equity: 49.29%
  • Return on Assets: 13.35%
  • Debt-to-Equity Ratio: 1.54%
  • Current Ratio: 2.05%
  • Quick Ratio: 1.69%
  • Average Volume: 546,244 shs.
  • Beta: 1.64
  • Short Ratio: 14.53

Frequently Asked Questions for Core Laboratories N.V. (NYSE:CLB)

What is Core Laboratories N.V.'s stock symbol?

Core Laboratories N.V. trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

How often does Core Laboratories N.V. pay dividends? What is the dividend yield for Core Laboratories N.V.?

Core Laboratories N.V. announced a quarterly dividend on Tuesday, October 10th. Shareholders of record on Friday, October 20th will be paid a dividend of $0.55 per share on Tuesday, November 21st. This represents a $2.20 annualized dividend and a yield of 2.42%. The ex-dividend date is Thursday, October 19th. View Core Laboratories N.V.'s Dividend History.

How were Core Laboratories N.V.'s earnings last quarter?

Core Laboratories N.V. (NYSE:CLB) released its earnings results on Monday, July, 24th. The company reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.51 by $0.01. The firm earned $163.90 million during the quarter, compared to analysts' expectations of $168.23 million. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. Core Laboratories N.V.'s revenue for the quarter was up 10.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.35 earnings per share. View Core Laboratories N.V.'s Earnings History.

When will Core Laboratories N.V. make its next earnings announcement?

Core Laboratories N.V. is scheduled to release their next quarterly earnings announcement on Monday, October, 23rd 2017. View Earnings Estimates for Core Laboratories N.V..

What guidance has Core Laboratories N.V. issued on next quarter's earnings?

Core Laboratories N.V. issued an update on its third quarter earnings guidance on Tuesday, September, 5th. The company provided EPS guidance of ~$0.44 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.56. The company issued revenue guidance of ~$161 million, compared to the consensus revenue estimate of $168.53 million.

Where is Core Laboratories N.V.'s stock going? Where will Core Laboratories N.V.'s stock price be in 2017?

13 analysts have issued 12 month price targets for Core Laboratories N.V.'s stock. Their predictions range from $91.00 to $136.00. On average, they expect Core Laboratories N.V.'s share price to reach $111.00 in the next twelve months. View Analyst Ratings for Core Laboratories N.V..

Who are some of Core Laboratories N.V.'s key competitors?

Who are Core Laboratories N.V.'s key executives?

Core Laboratories N.V.'s management team includes the folowing people:

  • David M. Demshur, Chairman of the Supervisory Board, President, Chief Executive Officer
  • Richard L. Bergmark, Chief Financial Officer, Executive Vice President, Member of the Supervisory Board
  • Monty L. Davis, Chief Operating Officer, Senior Vice President
  • Christopher S. Hill, Vice President, Chief Accounting Officer
  • Mark F. Elvig, Vice President, Secretary, General Counsel
  • Gwendolyn Y. Schreffler, Vice President, Corporate Development & Investor Relations
  • Martha Z. Carnes, Member of the Supervisory Board
  • Charles L. Dunlap, Member of the Supervisory Board
  • Jan Willem Sodderland, Member of the Supervisory Board
  • Michael Straughen, Member of the Supervisory Board

Who owns Core Laboratories N.V. stock?

Core Laboratories N.V.'s stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include WCM INVESTMENT MANAGEMENT (10.17%), Eqis Capital Management Inc. (0.01%) and Park National Corp OH (0.00%). Company insiders that own Core Laboratories N.V. stock include Jan Willem Sodderland, Martha Z Carnes and Michael Straughen. View Institutional Ownership Trends for Core Laboratories N.V..

Who bought Core Laboratories N.V. stock? Who is buying Core Laboratories N.V. stock?

Core Laboratories N.V.'s stock was purchased by a variety of institutional investors in the last quarter, including Park National Corp OH and Eqis Capital Management Inc.. Company insiders that have bought Core Laboratories N.V. stock in the last two years include Jan Willem Sodderland, Martha Z Carnes and Michael Straughen. View Insider Buying and Selling for Core Laboratories N.V..

How do I buy Core Laboratories N.V. stock?

Shares of Core Laboratories N.V. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Core Laboratories N.V.'s stock price today?

One share of Core Laboratories N.V. stock can currently be purchased for approximately $91.08.

MarketBeat Community Rating for Core Laboratories N.V. (NYSE CLB)
Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  240 (Vote Outperform)
Underperform Votes:  369 (Vote Underperform)
Total Votes:  609
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories N.V. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Core Laboratories N.V. (NYSE:CLB) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 7 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.31)
Consensus Price Target: $111.00 (21.87% upside)
Consensus Price Target History for Core Laboratories N.V. (NYSE:CLB)
Price Target History for Core Laboratories N.V. (NYSE:CLB)
Analysts' Ratings History for Core Laboratories N.V. (NYSE:CLB)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/18/2017Royal Bank Of CanadaReiterated RatingBuyN/AView Rating Details
10/10/2017Deutsche Bank AGInitiated CoverageBuy$109.00N/AView Rating Details
10/6/2017Cowen and CompanySet Price TargetHold$100.00N/AView Rating Details
8/24/2017Credit Suisse GroupUpgradeNeutral -> Outperform$110.00MediumView Rating Details
8/7/2017Morgan StanleyLower Price TargetOverweight -> Overweight$130.00 -> $125.00MediumView Rating Details
7/26/2017Citigroup Inc.Lower Price TargetNeutral$102.00 -> $100.00LowView Rating Details
7/26/2017Piper Jaffray CompaniesSet Price TargetHold$97.00MediumView Rating Details
4/22/2017ScotiabankSet Price TargetHold$136.00LowView Rating Details
4/21/2017ABN AmroUpgradeHoldLowView Rating Details
4/21/2017Loop CapitalUpgradeHold -> Buy$125.00 -> $130.00LowView Rating Details
3/23/2017Tudor PickeringInitiated CoverageHoldLowView Rating Details
12/7/2016StephensDowngradeEqual Weight -> Sell$91.00N/AView Rating Details
12/6/2016GuggenheimDowngradeBuy -> NeutralN/AView Rating Details
10/5/2016DA DavidsonInitiated CoverageBuy$136.00N/AView Rating Details
7/12/2016J P Morgan Chase & CoDowngradeNeutral -> UnderweightN/AView Rating Details
6/13/2016KLR GroupReiterated RatingBuy$166.00 -> $180.00N/AView Rating Details
4/23/2016SimmonsReiterated RatingHold$105.00 -> $115.00N/AView Rating Details
3/28/2016Howard WeilBoost Price Target$112.00N/AView Rating Details
2/10/2016ING GroupLower Price TargetHold$125.00 -> $112.00N/AView Rating Details
2/2/2016William BlairReiterated RatingOutperformN/AView Rating Details
1/29/2016SunTrust Banks, Inc.Lower Price TargetBuy$123.00 -> $109.00N/AView Rating Details
1/29/2016Iberia CapitalLower Price TargetOutperform$140.00 -> $115.00N/AView Rating Details
1/26/2016HSBC Holdings plcDowngradeHold -> ReduceN/AView Rating Details
1/11/2016Oppenheimer Holdings, Inc.Initiated CoverageMarket PerformN/AView Rating Details
(Data available from 10/18/2015 forward)


Earnings History for Core Laboratories N.V. (NYSE:CLB)
Earnings by Quarter for Core Laboratories N.V. (NYSE:CLB)
Earnings History by Quarter for Core Laboratories N.V. (NYSE CLB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/23/2017$0.61N/AView Earnings Details
7/24/20176/30/2017$0.51$0.52$168.23 million$163.90 millionViewN/AView Earnings Details
4/19/20173/31/2017$0.39$0.42$150.44 million$157.81 millionViewN/AView Earnings Details
1/25/201712/31/2016$0.41$0.41$145.78 million$149.54 millionViewN/AView Earnings Details
10/19/2016Q316$0.38$0.38$155.72 million$143.50 millionViewN/AView Earnings Details
7/20/2016Q216$0.35$0.35$146.37 million$148.10 millionViewN/AView Earnings Details
4/20/2016Q116$0.37$0.37$161.24 million$153.65 millionViewN/AView Earnings Details
1/27/2016Q415$0.65$0.65$179.48 million$182.70 millionViewListenView Earnings Details
10/21/2015Q315$0.83$0.83$203.29 million$197.27 millionViewListenView Earnings Details
7/22/2015Q215$0.77$0.82$195.13 million$204.00 millionViewListenView Earnings Details
4/22/2015Q115$0.85$0.86$211.82 million$213.64 millionViewN/AView Earnings Details
1/28/2015Q414$1.54$1.54$280.18 million$278.60 millionViewN/AView Earnings Details
10/22/2014Q314$1.52$1.53$284.30 million$276.14 millionViewListenView Earnings Details
7/23/2014Q214$1.35$1.35$269.70 million$267.56 millionViewListenView Earnings Details
4/23/2014Q114$1.45$1.45$283.02 million$262.90 millionViewListenView Earnings Details
1/30/2014Q413$1.40$1.43$278.55 million$276.30 millionViewListenView Earnings Details
10/17/2013Q313$1.34$1.36$267.21 million$273.16 millionViewN/AView Earnings Details
7/17/2013Q2 2013$1.31$1.32$267.24 million$263.14 millionViewListenView Earnings Details
4/17/2013Q1 2013$1.15$1.22$260.90 million$260.90 millionViewListenView Earnings Details
1/30/2013Q4 2012$1.13$1.17$246.49 million$254.46 millionViewListenView Earnings Details
10/17/2012$1.10$1.13ViewN/AView Earnings Details
7/18/2012$1.16$1.16ViewN/AView Earnings Details
4/18/2012$1.07$1.06ViewN/AView Earnings Details
2/1/2012$1.08$1.09ViewN/AView Earnings Details
10/19/2011$0.99$0.93ViewN/AView Earnings Details
4/19/2011$0.75$0.77ViewN/AView Earnings Details
2/9/2011$0.81$0.84ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Core Laboratories N.V. (NYSE:CLB)
2017 EPS Consensus Estimate: $2.62
2018 EPS Consensus Estimate: $3.44
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.39$0.81$0.53
Q2 20173$0.47$0.88$0.61
Q3 20173$0.55$0.97$0.72
Q4 20173$0.54$1.03$0.76
Q1 20181$0.73$0.73$0.73
Q2 20181$0.84$0.84$0.84
Q3 20181$1.00$1.00$1.00
Q4 20182$0.65$1.08$0.87
(Data provided by Zacks Investment Research)


Current Dividend Information for Core Laboratories N.V. (NYSE:CLB)
Next Dividend:11/21/2017
Annual Dividend:$2.20
Dividend Yield:2.42%
Dividend Growth:19.80% (3 Year Average)
Payout Ratio:134.15% (Trailing 12 Months of Earnings)
111.68% (Based on This Year's Estimates)
80.88% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Core Laboratories N.V. (NYSE:CLB)

Dividend History by Quarter for Core Laboratories N.V. (NYSE CLB)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Core Laboratories N.V. (NYSE:CLB)
Insider Ownership Percentage: 1.00%
Insider Trades by Quarter for Core Laboratories N.V. (NYSE:CLB)
Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)
Insider Trades by Quarter for Core Laboratories N.V. (NYSE:CLB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/1/2017Michael StraughenDirectorBuy106$118.65$12,576.90View SEC Filing  
1/30/2017Martha Z CarnesDirectorBuy200$115.20$23,040.00View SEC Filing  
2/2/2016Jan Willem SodderlandDirectorBuy300$93.90$28,170.00View SEC Filing  
5/12/2015Michael C KearneyDirectorSell1,000$128.52$128,520.00View SEC Filing  
11/17/2014Mark F ElvigVPSell1,000$138.03$138,030.00View SEC Filing  
7/28/2014Richard L BergmarkCFOBuy7,000$147.31$1,031,170.00View SEC Filing  
3/7/2014Michael KearneyDirectorSell2,000$193.00$386,000.00View SEC Filing  
2/14/2014Mark ElvigVPSell1,500$186.64$279,960.00View SEC Filing  
10/21/2013Monty L DavisCOOSell5,704$197.33$1,125,570.32View SEC Filing  
8/7/2013Richard BergmarkCFOSell20,000$149.58$2,991,600.00View SEC Filing  
7/25/2013Charles Brigham MillerCAOSell11,648$147.81$1,721,690.88View SEC Filing  
7/25/2013Monty L DavisCOOSell5,948$149.12$886,965.76View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Core Laboratories N.V. (NYSE:CLB)
Latest Headlines for Core Laboratories N.V. (NYSE:CLB)
DateHeadline logoDividend Coverage: This Energy Services Company has a Dividend Yield of 2.32%; Will Trade Ex-Dividend on October 19, 2017 - October 18 at 6:35 PM logoNabors Industries’ Short Interest on October 12 - October 18 at 6:35 PM logoCore Laboratories N.V.'s (CLB) Buy Rating Reiterated at Royal Bank Of Canada - October 18 at 11:38 AM logoCore Laboratories N.V. (CLB) Set to Announce Quarterly Earnings on Monday - October 16 at 2:50 AM logoReviewing Core Laboratories N.V. (CLB) and Geospace Technologies (OYOG) - October 12 at 12:56 PM logoCore Laboratories N.V. (CLB) Upgraded by Zacks Investment Research to Hold - October 12 at 12:20 AM logoCore Lab Announces Q4 2017 Quarterly Dividend - October 10 at 6:26 PM logoCore Laboratories N.V. Plans Quarterly Dividend of $0.55 (CLB) - October 10 at 6:00 PM logoCore Laboratories NV breached its 50 day moving average in a Bearish Manner : CLB-US : October 9, 2017 - October 9 at 5:51 PM logoWeatherford Reacted to Crude Oil Price Changes - October 9 at 5:51 PM logoCore Laboratories N.V. (CLB) PT Set at $100.00 by Cowen and Company - October 6 at 7:18 PM logoImplied IYE Analyst Target Price: $41 - October 5 at 11:21 AM logoCore Laboratories N.V. (CLB) Given Average Rating of "Hold" by Brokerages - October 5 at 12:36 AM logoCore Laboratories' Third Quarter 2017 Webcast At 7:30 AM CDT / 2:30 PM CEST On October 24, 2017 - PR Newswire (press release) - September 28 at 12:26 AM logoPre-Market Technical Pulse on Oil and Gas Stocks -- Tesco, C&J Energy Services, Core Labs, and Flotek Industries - PR Newswire (press release) - September 25 at 3:36 PM logoCore Laboratories NV – Value Analysis (NYSE:CLB) : September 19, 2017 - September 19 at 10:18 PM logoCore Laboratories NV breached its 50 day moving average in a Bullish Manner : CLB-US : September 18, 2017 - September 18 at 3:27 PM logoJPMorgan Has 5 Top Pick Oil Service Stocks for the Rest of 2017 - September 13 at 6:29 PM logoOil Companies on Slippery Ground as Harvey Hampers Production - September 12 at 5:53 PM logoCore Laboratories N.V. (CLB) Given Average Rating of "Hold" by Analysts - September 9 at 8:38 PM logoCorrelation between Crude Oil and Halliburton on September 5 - September 8 at 5:35 PM logoCore Laboratories N.V. (CLB) PT Lowered to $112.00 at Royal Bank Of Canada - September 7 at 1:00 PM logoCore Laboratories N.V. (CLB) Updates Q3 Earnings Guidance - September 5 at 9:10 PM logoCore Lab Reports On Impact Of Hurricane Harvey, Updates Third Quarter 2017 Guidance - September 5 at 6:47 PM logoCowen and Company Reaffirms Hold Rating for Core Laboratories N.V. (CLB) - September 4 at 9:26 PM logoCore Laboratories N.V. (CLB) Receives "Buy" Rating from Royal Bank Of Canada - September 2 at 6:20 AM logoFirst Week of October 20th Options Trading For Core Laboratories (CLB) - August 30 at 4:18 PM logoETFs with exposure to Core Laboratories NV : August 25, 2017 - August 25 at 6:59 PM logoCore Laboratories (CLB) Down 17.7% Since Earnings Report: Can It Rebound? - Nasdaq - August 25 at 3:24 AM logoCore Laboratories Stock Getting Very Oversold - August 24 at 5:21 PM logoCore Laboratories (CLB) Down 17.7% Since Earnings Report: Can It Rebound? - August 24 at 5:21 PM logoCore Laboratories NV : CLB-US: Dividend Analysis : July 17th, 2017 (record date) : By the numbers : August 24, 2017 - August 24 at 5:21 PM logoCore Laboratories N.V. (CLB) Upgraded to "Outperform" by Credit Suisse Group - August 24 at 3:56 PM logoCore Laboratories Stock Upgraded: What You Need to Know - August 24 at 2:47 PM logoBehind Baker Hughes’s Correlation with Crude in Mid-August - August 22 at 5:49 PM logoCorrelation between Weatherford and Crude Oil on August 18 - August 21 at 5:03 PM logoHow Core Laboratories N.V. Makes Most of Its Money - August 21 at 11:23 AM logoFlotek Industries’ Current Valuation versus Its Peers - August 18 at 5:18 PM logoNovember 17th Options Now Available For Core Laboratories (CLB) - Nasdaq - August 17 at 11:37 PM logoCore Laboratories N.V. (CLB) Given Consensus Rating of "Hold" by Brokerages - August 16 at 12:42 AM logoETFs with exposure to Core Laboratories NV : August 14, 2017 - August 14 at 5:37 PM logoOilfield Tech & Innovation Day: Heavy Hitters, Cutting Edge Technologies coming to EnerCom Denver - August 9 at 5:27 PM logoHead-To-Head Survey: Core Laboratories N.V. (NYSE:CLB) and Carbo Ceramics (CRR) - August 9 at 8:40 AM logoCorrelation between Weatherford and Crude Oil on August 4 - August 8 at 4:57 PM logoMorgan Stanley Lowers Core Laboratories N.V. (CLB) Price Target to $125.00 - August 7 at 10:58 AM logoNOW Inc's Results Continue Heading in the Right Direction - August 2 at 6:01 PM logoWhere the World Gets Its Power - July 31 at 5:11 PM logoCore Laboratories NV :CLB-US: Earnings Analysis: Q2, 2017 By the Numbers : July 31, 2017 - July 31 at 5:11 PM logoCore Laboratories N.V. (NYSE:CLB) Short Interest Update - July 31 at 7:04 AM logoWall Street’s Forecasts for TechnipFMC after Its 2Q17 Earnings - July 28 at 6:58 PM



Core Laboratories N.V. (CLB) Chart for Wednesday, October, 18, 2017

This page was last updated on 10/18/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.